Co-infection with SARS-CoV-2 and influenza A virus

Shuhei Azekawa; Ho Namkoong; Keiko Mitamura; Yoshihiro Kawaoka; Fumitake Saito

doi:10.1016/j.idcr.2020.e00775

Co-infection with SARS-CoV-2 and influenza A virus

IDCases. 2020 Apr 21:20:e00775. doi: 10.1016/j.idcr.2020.e00775. eCollection 2020.

Authors

Shuhei Azekawa¹, Ho Namkoong^{2

3}, Keiko Mitamura⁴, Yoshihiro Kawaoka^{5

6}, Fumitake Saito^{1

4}

Affiliations

¹ Department of Pulmonary Medicine, Eiju General Hospital, Tokyo, Japan.
² Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA.
³ Japan Society for the Promotion of Science, Tokyo, Japan.
⁴ Division of Infection Control, Eiju General Hospital, Tokyo, Japan.
⁵ Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
⁶ Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, WI, USA.

Abstract

Coronavirus Disease 2019 (COVID-19) infection, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is spreading globally and poses a major public health threat. We reported a case of influenza A virus and SARS-CoV-2 co-infection. As the number of COVID-19 cases increase, it will be necessary to comprehensively evaluate imaging and other clinical findings as well as consider co-infection with other respiratory viruses.

Keywords: COVID-19; Co-infection; Influenza; SARS-CoV-2.

Publication types

Case Reports